Cargando…
Development of a biosensor assessing SARS-CoV-2 main protease proteolytic activity in living cells for antiviral drugs screening
• The biosensor reported in our study can monitor SARS-CoV-2 M(pro) activity in living cells instead of in vitro solutions. • The biosensor reported in our study is sensitive and easy to operate. • It is suitable for high-throughput screening. • It has the potential to be used in small animal models...
Autores principales: | Zhang, Yuan, Li, Chunjie, Ke, Xianliang, Luo, Dan, Liu, Yan, Chen, Quanjiao, Wang, Hanzhong, Song, Xiaohui, Zheng, Zhenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wuhan Institute of Virology, Chinese Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060717/ https://www.ncbi.nlm.nih.gov/pubmed/35513272 http://dx.doi.org/10.1016/j.virs.2022.04.002 |
Ejemplares similares
-
Development of a luciferase-based biosensor to assess enterovirus 71 3C protease activity in living cells
por: Zhang, Yuan, et al.
Publicado: (2017) -
Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2
por: Behnam, Mira A.M.
Publicado: (2021) -
Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
por: Johansen-Leete, Jason, et al.
Publicado: (2022) -
In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease
por: Sivani, Bala Mohan, et al.
Publicado: (2021) -
SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense
por: Ju, Xiaohui, et al.
Publicado: (2023)